Background We sought to determine whether COPD conferred a higher risk for healthcare
utilization in terms of hospitalization and clinical outcomes due to COVID-19. Methods A …

As of August 24, 2020, over 23 million people around the world have been infected with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for …

Background and Objectives: Chronic obstructive pulmonary disease (COPD) is a leading
cause of death worldwide. Acute exacerbations (AECOPD) are common and often triggered …

Abstract Background The Coronavirus disease 2019 (COVID-19) pandemic has led to
widespread implementation of public health measures, such as stay-at-home orders, social …

Background Despite over 4 million cases of novel coronavirus disease 2019 (COVID-19) in
the United States, limited data exist including socioeconomic background and post …

Background: A global reduction in hospital admissions for acute exacerbations of chronic
obstructive pulmonary disease (AECOPD) was observed during the first months of the …

Importance After SARS-CoV-2 infection, many patients present with persistent symptoms for
at least 6 months, collectively termedpost-COVID conditions (PCC). However, the impact of …

Patients with Chronic Obstructive Pulmonary Disease (COPD) have a higher prevalence of
coronary ischemia and other factors that put them at risk for COVID-19-related …

The pandemic situation with the emergence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …

Background It is important that population cohorts at increased risk of hospitalisation and
death following a COVID‐19 infection are identified and protected. Objectives We identified …